FA
ELV icon

FMA Advisory’s Elevance Health ELV Stock Holding History

FMA Advisory’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		$664K Buy
1,781
+3
+0.2% +$1.14K 0.25% 98
2021
Q2 		$679K Sell
1,778
-48
-3% -$18.3K 0.25% 90
2021
Q1 		$655K Buy
1,826
+3
+0.2% +$965 0.2% 118
2020
Q4 		$585K Buy
1,823
+3
+0.2% +$921 0.2% 122
2020
Q3 		$489K Buy
1,820
+4
+0.2% +$1.08K 0.19% 119
2020
Q2 		$478K Buy
1,816
+2
+0.1% +$534 0.21% 112
2020
Q1 		$412K Sell
1,814
-2
-0.1% -$545 0.22% 105
2019
Q4 		$549K Buy
1,816
+1
+0.1% +$275 0.22% 109
2019
Q3 		$436K Buy
1,815
+1
+0.1% +$274 0.19% 119
2019
Q2 		$512K Sell
1,814
-455
-20% -$124K 0.23% 110
2019
Q1 		$651K Sell
2,269
-248
-10% -$71.7K 0.3% 92
2018
Q4 		$661K Sell
2,517
-192
-7% -$52.8K 0.34% 82
2018
Q3 		$743K Buy
2,709
+5
+0.2% +$1.3K 0.33% 85
2018
Q2 		$644K Buy
2,704
+544
+25% +$126K 0.3% 91
2018
Q1 		$475K Buy
2,160
+3
+0.1% +$705 0.23% 103
2017
Q4 		$485K Buy
2,157
+849
+65% +$181K 0.23% 107
2017
Q3 		$248K Buy
1,308
+1
+0.1% +$190 0.15% 121
2017
Q2 		$245 Sell
1,307
-845
-39% -$152K 0.13% 102
2017
Q1 		$356K Buy
+2,152
New +$342K 0.18% 117
2015
Q2 		$423K Buy
+2,576
New +$412K 0.26% 87
2014
Q4 		$1.71M Buy
13,607
+61
+0.5% +$7.54K 0.6% 65
2014
Q3 		$1.62M Sell
13,546
-274
-2% -$31.4K 0.6% 66
2014
Q2 		$1.49M Sell
13,820
-33
-0.2% -$3.4K 0.55% 73
2014
Q1 		$1.38M Buy
13,853
+47
+0.3% +$4.25K 0.54% 74
2013
Q4 		$1.27M Buy
13,806
+188
+1% +$16.7K 0.52% 80
2013
Q3 		$1.14M Buy
13,618
+7
+0.1% +$600 0.45% 80
2013
Q2 		$1.11M Buy
+13,611
New +$1.02M 0.47% 81

Other funds holding ELV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Sanders Capital
Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return

FMA Advisory's ELV Position: Q3 2021 in Review

FMA Advisory increased its Elevance Health (ELV) stake by 0.17% in Q3 2021, buying an estimated $1.14K and bringing the position to 1,781 shares worth $664K. The position accounts for 0.25% of the portfolio, ranked #98.

FMA Advisory first reported a position in ELV in Q2 2013 and has held it in 27 quarters since. The position peaked at $1.71M in Q4 2014. 1,214 funds tracked by Wall St. Rank hold ELV as of Q3 2021.

  • FMA Advisory held 1,781 shares of Elevance Health worth $664K as of Q3 2021.
  • FMA Advisory bought 3 Elevance Health shares in Q3 2021, an estimated $1.14K.
  • Elevance Health made up 0.25% of FMA Advisory's portfolio in Q3 2021, its #98 holding.
  • FMA Advisory first reported a position in Elevance Health in Q2 2013 and has held it in 27 quarters since.
  • FMA Advisory's Elevance Health position peaked at $1.71M in Q4 2014.
  • 1,214 funds tracked by Wall St. Rank held Elevance Health as of Q3 2021.

Based on FMA Advisory's 13F filing for Q3 2021, filed 15 Nov 2021.